Serum prolactin and gonadal hormones in hemodialysis women: a meta-analysis.
Journal Information
Full Title: BMC Endocr Disord
Abbreviation: BMC Endocr Disord
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Endocrinology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Competing interestsThe authors declare no competing interests. Ethics approval and consent to participateNot Applicable. Consent for publicationNot Applicable. FoundingNo funds, grants, or other support was received. Financial interestsNone. Competing interests The authors declare no competing interests."
"Declarations: Competing interestsThe authors declare no competing interests.: Ethics approval and consent to participateNot Applicable.: Consent for publicationNot Applicable.: FoundingNo funds, grants, or other support was received.: Financial interestsNone. Founding: No funds, grants, or other support was received."
"After merging citations and eliminating duplications manually, two reviewers screened titles and abstracts independently to obtain eligible articles. Studies potentially containing relevant data were retained initially. A third author joined to make a consensus when disagreement occurred. The study was registered in PROSPERO to further enhance the transparency and to better explain issues arising during research. The register number was CRD42023394503. Methods: Literatures were searched in PubMed, Cochrane library, Embase, and Web of science before March 11, 2023. Trial sequential analysis (TSA) was performed to test the conclusiveness of this meta-analysis. Egger’s test and trim-and-fill analysis was used to test publication bias. We took standardized mean difference (SMD) as pool effect of hormones values including prolactin (PRL), follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2) and progesterone (P). This study was registered in PROSPERO and the number was CRD42023394503."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025